Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Tiffany Mayo
Best Practices for Managing Pseudofolliculitis Barbae : An Expert Consensus Delphi Study
Best Practices for Managing Pseudofolliculitis Barbae: An Expert Consensus Delphi Study Abstract Importance Pseudofolliculitis barbae (PFB) is a chronic inflammatory disease caused by penetration of a shaved, curved hair shaft into the skin. Standardized recommendations for diagnosing and managing PFB are needed. Objective To establish expert consensus recommendations outlining best practices for diagnosing and managing PFB.
How Women of Color in Medicine Navigate Representation Pressure
Published on: , This segment of The Medical Sisterhood podcast highlights setting boundaries in mentorship and the pressure of representation for women of color in medicine. Leadership in medicine rarely comes with a manual for what happens outside the clinic.
How Boundary-Setting as a Physician Leader Can Be Challenging, With Tiffany Mayo, MD
Published on: , Tiffany Mayo, MD, reflects on the pressure of visibility in medical leadership and why boundary-setting becomes essential.
The Medical Sisterhood: The Pressure of Representation, With Tiffany Mayo, MD
Tiffany Mayo, MD, associate professor at the University of Alabama at Birmingham who will soon join UT Southwestern in Dallas, joined host Mona Shahriari, MD, associate clinical professor of dermatology at Yale University, on The Medical Sisterhood podcast to discuss what she called the pressure of representation that comes after becoming a leader in medicine.
Skin of Color Savvy: Live at RAD 2025 with Tiffany Mayo, MD, and Raj Chovatiya, MD, PhD
Welcome to Skin of Color Savvy: The Art and Science of Treating Patients of Color! In this special on-site episode of Skin of Color Savvy: The Art and Science of Treating Patients of Color, by the Skin of Color Society (SOCS) and HCPLive, dermatologists Raj Chovatiya, MD, PhD, and Tiffany Mayo, MD, engage in a wide-ranging discussion on atopic dermatitis in skin of color, recorded live from the 2025 Revolutionizing Atopic Dermatitis (RAD) Conference in Nashville, Tennessee.
Complex Cases in Atopic Dermatitis and Hair Loss, with Tiffany Mayo, MD
During the 2025 Revolutionizing Atopic Dermatitis (RAD) Conference in Nashville, Tennessee, Tiffany Mayo, MD, provided a Q&A interview to the HCPLive editorial team regarding takeaways from her conference talk, ‘Complex Cases: AD & Hair Loss.’ Mayo is known for her work as both a board-certified dermatologist and assistant professor of Dermatology at the University of Alabama at Birmingham.
Spotlighting Complex Cases of Atopic Dermatitis and Hair Loss, with Tiffany Mayo, MD
In a talk given at the 2025 Revolutionizing Atopic Dermatitis (RAD) Conference in Nashville, TN, Tiffany Mayo, MD, discussed the association between atopic dermatitis and alopecia, emphasizing the need to address hair loss in patients with atopic dermatitis and address patients' concerns in a more well-rounded manner.
Skin of Color Savvy: HS Management in Skin of Color, with Tiffany Mayo, MD, Steven Daveluy, MD, Jasmine Ivanna Espy
Welcome to Skin of Color Savvy: The Art and Science of Treating Patients of Color! In this special episode of Skin of Color Savvy: The Art and Science of Treating Patients of Color, host Tiffany Mayo, MD, leads a dynamic conversation on hidradenitis suppurativa (HS) in patients with diverse skin types, joined by dermatologist Steven Daveluy, MD, and patient advocate Jasmine Ivanna Espy.
Updates on disorders in curly hair
References 1, , , , , . Quality of life in South African Black women with alopecia: a pilot study. Int J Dermatol. 2016; 55(8): 875–881. https://doi.org/10.1111/ijd.13042 2, , , , . Black women's hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity. An Bras Dermatol. 2015; 90(4): 450–465. https://doi.org/10.1590/abd1806-4841.20152845 3, , , et al. Variant PADI3 in central centrifugal cicatricial alopecia. N Engl J Med. 2019; 380(9): 833–841.
Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
Key Points Question What is the benefit of uptitration to baricitinib, 4 mg, for 24 weeks among patients with severe alopecia areata who did not respond to baricitinib, 2 mg (Severity of Alopecia Tool score >20), after 52 weeks of therapy? Findings In this pooled analysis of 2 phase 3 randomized clinical trials, 25% of baricitinib, 2 mg, nonresponders who uptitrated to baricitinib, 4 mg, achieved at least 80% scalp coverage (Severity of Alopecia Tool score ≤20) by week 76.
Efficacy and safety of up to two years of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis
Main Article Content Keywords atopic dermatitis, tralokinumab References 1. Weidinger S, Novak N. Lancet. 2016;387(10023):1109-1122. 2. Kaufman B, et al. Exp Dermatol 2018; 27: 340-357. 3. Blauvelt A, et al. J Am Acad Dermatol. 2022;S0190-9622(22)02345-3. Article Sidebar Article Details How to Cite Mayo, T., Armstrong, A., Kircik, L., Silverberg, J., Blauvelt, A., Esdaile, B., Schneider, S., Mark, T., Gooderham, M., & Alexis, A. (2023).
Efficacy and safety of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials | SKIN The Journal of Cutaneous Medicine
Main Article Content Keywords atopic dermatitis, eczema, racial subgroup, phase 3, clinical trial, efficacy, safety References 1. Kaufman B, et al. Exp Dermatol 2018; 27: 340-357 2. Wollenberg A, et al. Br J Dermatol. 2021; 184(3)437-449 3. Silverberg J, et al. Br J Dermatol. 2021; 184(3)450-463 Article Sidebar Article Details How to Cite Mayo, T., Armstrong, A. W., Kircik, L., Silverberg, J. I., Blauvelt, A., Esdalie, B., Schneider, S., Mark, T., Gooderham, M., & Alexis, A. F. (2022).
Verrucous Scalp Plaque and Widespread Eruption
Laboratory workup including a complete blood cell count with differential, comprehensive metabolic panel, antinuclear antibodies, Sjögren syndrome A and B antibodies, hepatitis profile, rapid plasma reagin, HIV screen, aldolase, anti–Jo-1, T-Spot TB test (Quest Diagnostics), and tissue cultures was unremarkable. Two 4-mm punch biopsies were obtained from the left cheek and upper back, both of which demonstrated intragranular acantholysis suggestive of pemphigus foliaceous (Figure 1A).
Analyzing the Relationship Between Altmetric Score and Literature Citations in the Dermatology Literature
Main Article Content Meredith E Thomley University of Alabama at Birmingham http://orcid.org/0000-0003-3068-4530 Ana Preda-Naumescu University of Alabama at Birmingham Carter J Boyd New York University Langone Health Tiffany Mayo University of Alabama at Birmingham Department of Dermatology Keywords Citations, Bibliometric, peer-review, social media, Altmetric Abstract Background: Standard bibliometric methods used in dermatologic research include impact factor and citations.
Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata: A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 Trials
Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata: A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 Trials Autores: Justin M. Ko, Tiffany T. Mayo, Wilma F. Bergfeld, Yves Dutronc, Guanglei Yu, Susan G. Ball, Najwa Somani, Brittany G. Craiglow Localización: JAMA Dermatology, ISSN 2168-6068, Vol. 159, Nº. 9, 2023, págs.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Tiffany
Contact Tiffany, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack